Related by context. All words. (Click for frequent words.) 75 lymph node metastasis 74 mucinous 73 lymph node metastases 72 extracapsular extension 72 axillary lymph node 71 pT3 71 axillary node 71 micrometastasis 71 FDG uptake 71 Histologic 71 histologic subtype 70 tumoral 70 urothelial carcinoma 70 mediastinal 70 echogenicity 70 nodal metastasis 70 SLNB 70 nodal metastases 70 histologic 69 hypointense 69 clinicopathological features 69 immunoreactivity 69 seminal vesicle invasion 69 CIN2 + 69 splenic 69 luminal 69 breast carcinomas 69 histopathologic examination 69 lymph node involvement 68 ERBB2 68 gastric adenocarcinoma 68 endometrioid 68 HER2 expression 68 immunohistochemical analysis 68 Lymph node 68 parenchymal 68 malignant nodules 68 urothelial 68 mRNA expression 68 T2 weighted images 68 histopathologic 68 pT2 68 epithelial tumors 68 immunostaining 68 renal cell carcinomas 68 SUVmax 68 univariate analysis 68 CD# expression [001] 68 ductal 68 hormone receptor negative 67 microvessel density 67 scintigraphic 67 neoplasm 67 histopathological 67 malignant lesions 67 metastatic lymph nodes 67 renal pelvis 67 pathologic examination 67 biochemical recurrence 67 histological subtype 67 HRCT 67 lymphocytosis 67 ERalpha 67 axillary lymph nodes 67 sarcomatoid 67 papillary 67 thyroid carcinoma 67 breast carcinoma 67 invasive carcinomas 67 node metastases 67 peritumoral 67 clinicopathological 67 mesenteric 67 lobular carcinoma 67 BRAF V#E mutation 67 hyperintensity 67 HGPIN 67 perineural invasion 67 progesterone receptor PR 67 cytokeratin 66 invasive lobular 66 Immunohistochemical staining 66 advanced adenomas 66 TIMP 66 invasive carcinoma 66 micrometastases 66 gastric carcinoma 66 histologic findings 66 bone scintigraphy 66 tracer uptake 66 FDG-PET/CT 66 prostate cancer CaP 66 lymphocytic 66 ultrasonographic 66 locoregional 66 HER2 overexpression 66 distant metastasis 66 Papillary 66 prostate carcinoma 66 sonographic findings 66 locoregional recurrence 66 preoperative PSA 66 Immunohistochemical analysis 66 immunoreactive 66 cytologic 66 TMPRSS2 ERG fusion 66 cervical lymph nodes 66 advanced adenoma 66 sonographically 66 liver metastasis 66 axillary nodes 66 immunohistochemical 66 submucosal 66 paragangliomas 65 prognostic factor 65 thyroglobulin 65 radiographic findings 65 estrogen receptor ER 65 cellularity 65 prostatic adenocarcinoma 65 histologically 65 gadolinium enhanced 65 esophageal carcinoma 65 metachronous 65 hyperplastic 65 Doppler sonography 65 pulmonary metastases 65 NMIBC 65 atypical hyperplasia 65 calculi 65 multivariate analyzes 65 Ki# 65 TIMP 1 65 colorectal adenocarcinoma 65 hamartomas 65 sentinel node 65 invasive ductal 65 clinicopathologic 65 tumor histology 65 extranodal 65 PCa 65 nonmetastatic 65 mediastinum 65 colorectal neoplasms 65 polypoid 65 intact parathyroid hormone 65 surgically resected 65 metastatic lesions 65 proximal colon 65 completely resected 65 papillary thyroid carcinoma 65 prognostic indicator 65 immunohistochemical staining 65 contralateral breast 65 pCR 65 distal colon 65 extracranial 64 intraobserver 64 operable breast cancer 64 breast cancer subtypes 64 lactate dehydrogenase 64 hypervascular 64 HER2 amplification 64 hydronephrosis 64 neoplasms 64 neoplastic 64 transabdominal 64 progesterone receptor 64 F FDG PET 64 EUS FNA 64 Histological examination 64 colorectal adenoma 64 hyperintensities 64 multivariable analysis 64 CIN3 64 microsatellite instability 64 heparanase 64 urine cytology 64 thyroid nodule 64 inducible nitric oxide synthase 64 HBeAg 64 lobular carcinomas 64 obstructive coronary artery 64 adrenocortical 64 Histological 64 ischemic lesions 64 gene polymorphisms 64 tumorigenicity 64 ductal carcinomas 64 distant metastases 64 leukocytosis 64 adenocarcinomas 64 hilar 64 adenoma 64 epididymal 64 lobular 64 malignant prostate 64 hematoxylin eosin original 64 poorer prognosis 64 thyroid peroxidase 64 extramedullary 64 choroidal 64 prognostic significance 64 RRM1 64 BRCA1 mutation carriers 64 ^ sup #m 64 Histopathologic 64 leiomyomas 64 intratumoral 64 MLH1 64 alveolar epithelial cells 64 SNP rs# [002] 64 Univariate analysis 64 carcinoids 64 ovarian carcinoma 64 gastric cardia 64 florbetaben 64 BRAF V#E 64 GISTs 64 alkaline phosphatase ALP 64 T1 weighted images 64 BCR ABL mutations 64 T1a 64 anti JCV antibodies 64 hepatocellular carcinomas 64 squamous intraepithelial lesions 64 biopsy specimen 64 histologically proven 64 osteochondroma 64 enhanced sonography 64 grade squamous intraepithelial 64 lymphadenectomy 63 lung metastasis 63 P = .# 63 Alkaline Phosphatase 63 mediastinal lymph nodes 63 neoplasias 63 adenomatous 63 thyroid carcinomas 63 renal cortical 63 para aortic 63 Fine needle aspiration 63 vimentin 63 fractional anisotropy 63 morphologic 63 synovial 63 T2 weighted MRI 63 pathologic diagnosis 63 Adenomas 63 TRUS 63 Figure 2C 63 mucosal inflammation 63 T1c 63 Angiotensin converting enzyme 63 seminal vesicle 63 CagA 63 leiomyoma 63 T2 lesions 63 Histologically 63 lymphadenopathy 63 FDG PET 63 computed tomographic 63 bronchioloalveolar carcinoma 63 periventricular 63 pituitary adenomas 63 haematopoietic 63 cagA 63 endometrial carcinoma 63 ASCUS 63 SNP rs# [001] 63 colorectal carcinoma 63 haematologic 63 radical prostatectomy RP 63 rs# [004] 63 TNM staging 63 tonsillar 63 tumor necrosis 63 EGFR mutation positive 63 HBsAg 63 Immunohistochemistry 63 transvaginal sonography 63 MTT assay 63 glomerular 63 advanced neoplasia 63 CP CPPS 63 malignant ovarian 63 endobronchial 63 K ras mutations 63 univariate 63 assay detects 63 progesterone receptor negative 63 ultrastructural 63 ^ Tc 63 gastroduodenal 63 IL 1ß 63 specific antigen PSA 63 Multivariate analysis 63 perivascular 63 bronchial epithelial cells 63 cell adhesion molecule 63 echogenic 63 intrahepatic 63 VEGF expression 63 necrotic core 63 stromal 63 TMPRSS2 ERG 63 TNF α 63 resected 63 interobserver 63 #F FDG 63 biopsy Gleason 62 squamous cell carcinoma SCC 62 endometrial adenocarcinoma 62 myocardial perfusion 62 contralateral 62 renal cysts 62 histologic subtypes 62 histologic examination 62 multivariate Cox 62 pleomorphic 62 pathologic 62 undetectable HBV DNA 62 vascularisation 62 adjuvant radiotherapy 62 urodynamic 62 cytologically 62 cardiac perfusion 62 myometrium 62 multivariate analysis 62 mesotheliomas 62 eosinophil count 62 HER2 positivity 62 FDG PET imaging 62 obstructive CAD 62 steroidogenic 62 metastatic lesion 62 stenoses 62 cisplatin resistant 62 fig. S4 62 precursor lesions 62 cathepsin B 62 detrusor 62 osteoblastic 62 coronary stenosis 62 trabecular 62 serum prostate 62 CC genotype 62 sentinel nodes 62 parasitaemia 62 #F FDG PET 62 intestinal metaplasia 62 sentinel lymph node biopsy 62 hamartoma 62 pleural fluid 62 underwent surgical resection 62 PTPN# 62 SPINK1 62 ABCB1 62 pancreatic adenocarcinoma 62 immunoblotting 62 brain parenchyma 62 radiotherapy RT 62 lymphopenia 62 astrocytomas 62 cervical intraepithelial neoplasia 62 hormone receptor status 62 Prognostic factors 62 Leydig cell 62 airway hyperresponsiveness 62 parenchyma 62 Figure 1C 62 estrogen receptor progesterone receptor 62 resected tumors 62 fibrin deposition 62 atherosclerotic lesion 62 microglial 62 coexpression 62 angiographically 62 PSADT 62 MALT lymphoma 62 ductal lobular 62 COL#A# 62 graft dysfunction 62 extrapulmonary 62 isoprostane 62 synovial tissue 62 PSA kinetics 62 metaplasia 62 transgenic mice expressing 62 LV ejection fraction 62 grade cervical intraepithelial 62 lymphoid 62 AGTR1 62 tryptase 62 Preoperatively 62 baseline LDH 62 microvessel 62 thyroid nodules 62 lesional 62 Endometrial 62 transesophageal echocardiography 62 situ LCIS 62 constitutively active 62 pancreatic carcinoma 62 sonographically guided 62 carotid artery thickness 62 myxoid 62 retroperitoneal 62 opacification 62 Western blotting 62 GSTP1 62 prostatic 62 rs# [002] 62 small lymphocytic lymphoma 62 oncologic outcomes 62 cTnI 62 ER alpha 62 multicentric 62 thalamic 62 TGFß 62 Circulating tumor cells 62 hypoechoic 62 basal epithelial 62 F FLT 62 tumor perfusion 62 supratentorial 62 prostatic tissue 62 neoplastic lesions 62 resectable 62 % CI #.#-#.# [007] 62 Doppler ultrasonography 62 Leydig cells 62 seminal vesicles 62 MDCTA 62 intima media thickness 62 μg ml 61 Estrogen receptor 61 duodenal 61 precancerous cervical 61 carcinoembryonic antigen 61 oropharyngeal 61 PSA nadir 61 ipsilateral 61 clinico pathological 61 quantitative computed tomography 61 biochemical relapse 61 adenomatous polyps 61 myocardial necrosis 61 p# antigen 61 immunocytochemistry 61 VEGFR1 61 atheroma volume 61 LVNC 61 esophageal varices 61 Histopathologic examination 61 sonographic 61 serous ovarian cancer 61 pulsed Doppler 61 proteoglycan 61 F FDG uptake 61 Annexin V 61 NPM1 mutation 61 hematopoietic cancers 61 germline mutations 61 osteoid 61 cervical carcinoma 61 hypermethylated 61 percutaneous biopsy 61 carotid stenosis 61 pheochromocytomas 61 erythrocyte sedimentation rate 61 colonic polyps 61 plain radiographs 61 cytological 61 esophageal squamous cell carcinoma 61 transgene expression 61 T1 weighted 61 vascular endothelial 61 neovascular 61 malignant neoplasm 61 TOP2A gene 61 mutated K ras 61 seropositivity 61 histological diagnosis 61 adnexal mass 61 ligand induced 61 papillary renal cell carcinoma 61 BRAF mutations 61 #.#ng/ml 61 laterality 61 preoperative diagnosis 61 β amyloid 61 posttreatment 61 neutropaenia 61 Computed tomography 61 hyperplastic polyps 61 colorectal tumor 61 creatinine ratio 61 normal karyotype 61 CD#b 61 fluorescence intensity 61 Mammographic 61 osteosarcomas 61 peritoneal carcinomatosis 61 HER2 receptor 61 axillary dissection 61 extracapsular 61 adnexal masses 61 monocytic 61 Breslow thickness 61 nodular 61 HCT# 61 hyperintense lesions 61 lung metastases 61 parathyroid 61 preoperative chemotherapy 61 liver histology 61 renal tumors 61 #ß 61 clonogenic 61 Helicobacter pylori infection 61 myofibroblasts 61 adventitia 61 GNAQ 61 mononuclear 61 pAkt 61 sleeve lobectomy 61 carboxyl terminal 61 lactate dehydrogenase LDH 61 metastatic neuroendocrine tumors 61 TNFalpha 61 lymphoid cells 61 AT1R 61 NP CRNs 61 bladder carcinoma 61 TT genotype 61 CIN3 + 61 pmol L 61 transrectal ultrasound guided 61 isoenzyme 61 Figure 1A 61 inotropic 61 carcinomatosis 61 Supplementary Table 61 HOMA IR 61 serum PTH 61 E selectin 61 mammographically 61 Prostate specific antigen 61 neointimal 61 unresectable tumors 61 hyperintense 61 cytologically confirmed 61 C. pneumoniae 61 chest radiograph 61 bronchoalveolar 61 CD#c 61 pancreatic prostate 61 germinal center 61 skeletal metastases 61 SLC#A# [002] 61 transitional cell carcinoma 61 abdominal computed tomography 61 CD# CD# 61 multivariate adjustment 61 nitrotyrosine 61 etiologic 61 esophagogastric junction 61 demyelinating 61 B7 H3 61 umbilical vein 61 cystoscopic 61 sensory neuropathy 61 gene polymorphism 61 HER2 neu 61 carotid bruit 61 inhibin B 61 renal carcinoma 61 diffusion tensor 61 aggrecan 61 troponin T 61 interobserver agreement 61 micronuclei 61 downregulated 61 SSc 61 IL#B 61 Computed tomographic 61 affective psychosis 61 malignant fibrous histiocytoma 61 biopsied breast 61 PON1 gene 61 hematologic toxicity 61 BRCA2 mutation carriers 61 metastatic prostate 61 granulosa cell 61 Preoperative 61 CD# expression [002] 61 oligodendroglioma 61 myometrial 61 aminotransferase 61 monocyte chemoattractant protein 61 amyloid deposition 61 occult metastases 60 supraclavicular 60 Microarray analysis 60 bladder tumors 60 N telopeptide 60 carcinoid tumor 60 redox active 60 hematoxylin 60 macrophage infiltration 60 colorectal carcinomas 60 tissue biopsies 60 sarcosine 60 LV dysfunction 60 myocardial viability 60 pancreatic duct 60 sensitivity specificity 60 annexin V 60 histologically confirmed 60 osteogenic 60 intraepithelial neoplasia 60 oral squamous cell 60 progesterone receptors 60 cervical lymph node 60 pulmonary nodules 60 endometrial thickness 60 digital subtraction angiography 60 P selectin 60 hepatoma 60 postoperative morbidity 60 KRAS mutation 60 genetic loci 60 N. gonorrhoeae 60 perineural 60 cytolytic activity 60 Macrophage 60 β1 60 peritoneal 60 stent stenosis 60 T2 weighted 60 submucosa 60 CIN2 60 neoadjuvant therapy 60 bronchogenic carcinoma 60 microcalcifications 60 perfusion abnormalities 60 squamous 60 pelvic lymphadenectomy 60 EGFR receptor 60 choroidal neovascularization 60 leucopenia 60 tunica vaginalis 60 subcellular localization 60 underwent resection 60 epithelial ovarian 60 elevated LDH 60 Immunohistochemical 60 extrahepatic 60 rebleeding 60 radiosensitivity 60 mesangial 60 homozygotes 60 sulcal 60 heterozygotes 60 uranophane 60 noncalcified 60 glutamic acid decarboxylase 60 intraoperative complications 60 melanocytic 60 chemoembolization 60 orthotopic 60 5alpha reductase 60 Fig. 1D 60 null mice 60 Akt activation 60 caveolin 1 60 papillary carcinoma 60 adipogenic 60 pericardial effusion 60 natriuretic peptides 60 chromophobe 60 lymphoid tissue 60 cortical atrophy 60 radical nephrectomy 60 ventilation perfusion 60 epithelia 60 C telopeptide 60 polymorphonuclear 60 rheumatoid factor 60 Oropharyngeal 60 anti HBs 60 activating mutations 60 EGF receptors 60 prognostic marker 60 neurofibromas 60 familial aggregation 60 H pylori 60 chromosome #p# [002] 60 BRCA mutation carriers 60 bronchoalveolar lavage 60 astrocytoma 60 Estrogen Receptor 60 pancreatic lung 60 dysplastic 60 LPS induced 60 osteoid osteoma 60 aneurysmal 60 osteoclastic 60 peritoneal fluid 60 Kruskal Wallis test 60 epithelioid 60 mononuclear cells 60 left ventricular LV 60 sonographic appearance 60 hypoperfusion 60 serum PSA 60 postoperative chemotherapy 60 gastric mucosa 60 TOP2A 60 TGF ß 60 sCJD 60 medullary 60 P cadherin 60 lung nodules 60 KRAS mutations 60 CDK4 60 apparent diffusion coefficient 60 DNA methylation patterns 60 MGUS 60 neoadjuvant chemotherapy 60 promoter methylation 60 SLN biopsy 60 highest tertile 60 squamous carcinoma 60 colocalization 60 serum antibodies 60 prognostic variables 60 NAbs 60 CXCR4 expression 60 metastases 60 thymoma 60 cholelithiasis 60 endocervical 60 elevated ALT 60 prostate abnormalities 60 TP# mutations 60 histological subtypes 60 intestinal permeability 60 apolipoproteins 60 chemosensitivity 60 endothelial activation 60 colorectal adenomas 60 premalignant lesions 60 pituitary adenoma 60 cholangiocarcinoma 60 arteriography 60 trophoblast cells 60 core needle biopsies 60 HER2 positive cancers 60 interobserver reliability 60 epithelial cell 60 perfusion defect 60 hypothalamic pituitary 60 cerebellar 60 wedge resection 60 CEACAM1 60 cTnT 60 paraneoplastic 60 prognostic biomarker 60 Kaplan Meier analysis 60 HER2/neu 60 adrenal cortex 60 response pCR 60 LHRH receptor positive 60 malignant transformation 60 histological 60 total thyroidectomy 60 computed tomographic scan 60 MDCT angiography 60 ciliary body 60 astrocytic 60 FGFR4 60 EpCAM expression 60 anterior temporal 60 dysuria 60 enterococcal 60 AST ALT 60 hepatic lesions 60 pelvic lymph nodes 60 lesion 60 qRT PCR 60 urothelial cancer 60 WT1 60 Fig. 3b 60 prostate cancer PCa 60 intraductal 60 chromosome #p#.# 60 serum TSH 60 transmural 60 PITX2 60 constitutively expressed 60 tubule 60 lymphatic tissue 60 EGFR expression 60 villous 59 immunofluorescence staining 59 erythroid 59 syngeneic 59 missense mutations 59 Fibroblast 59 apical 59 morphologic characteristics 59 FGFR3 59 T#I [002] 59 K#R [002] 59 anaplastic 59 MDA MB 59 CCR9 59 epithelial cells lining 59 serum thyroglobulin 59 intraabdominal 59 ertapenem 59 HOXB# 59 adenomyosis 59 ERK1 2 59 microRNA expression 59 nonalcoholic steatohepatitis NASH 59 -#.# ± [002] 59 arthrography 59 color Doppler sonography 59 ultrasound elastography 59 oncogenic mutations 59 Supplementary Fig 59 Cystatin C 59 TUNEL 59 biliary tract cancer 59 T#M 59 annexin 59 pDC 59 tertiles 59 carotid plaque 59 carcinoid tumors 59 cAMP signaling 59 CR nPR 59 Squamous 59 PCNSL 59 duplex ultrasonography 59 protein tyrosine phosphatase 59 ERK signaling 59 microvessels 59 p# activation 59 serum markers 59 myeloperoxidase 59 trabecular bone 59 papillomas 59 malignant lymphoma 59 HER2 negative 59 hypercoagulable 59 osteoprotegerin 59 enteroviral 59 lung carcinomas 59 immunofluorescence 59 intraperitoneal 59 BRCA2 carriers 59 plasma pharmacokinetics 59 hepatocellular 59 nonmalignant 59 haematological 59 p# mutations 59 breast lesions 59 monocyte 59 adrenalectomy 59 factor PlGF 59 Ultrasonographic 59 liver parenchyma 59 precancerous tissues 59 dysplastic lesions 59 sinonasal 59 iNOS 59 osteolytic 59 parous women 59 sentinel lymph nodes 59 Sentinel lymph node 59 D Dimer 59 ELISpot 59 infiltrating ductal carcinoma 59 intravesical therapy 59 Metastatic 59 Sjögren syndrome 59 HbF 59 MDR1 59 gadolinium enhancing 59 lung nodule 59 induced sputum 59 MSH2 59 hyperechoic 59 #OHD 59 IL6 59 anogenital 59 CTNNB1 59 Radical prostatectomy 59 microbleeds 59 lupus anticoagulant 59 immunofluorescence microscopy 59 CD# + [001] 59 Gram stain 59 atherosclerotic lesions 59 ductal adenocarcinoma 59 nutlin 3a 59 semiquantitative 59 chrome diopside 59 confidence intervals CIs 59 Hurthle cell 59 pheochromocytoma 59 metastatic gastric 59 histologies 59 Mutational 59 renal artery stenosis 59 RASSF1A 59 neoplastic cells 59 ADRB2 59 erythrocyte 59 somatostatin receptor 59 lymphangiogenesis 59 D dimer 59 potent inhibitory 59 IPAH 59 pre malignant lesions 59 proximal tubule 59 pulmonary metastasis 59 endometrial 59 bivariate 59 seminomas 59 N acetylaspartate 59 coronary artery stenosis 59 locoregional disease 59 debulking surgery 59 BRCA deficient 59 Epstein Barr Virus EBV 59 Angiographic 59 estrogen receptor negative 59 FDG PET CT 59 carcinomas 59 multivariate logistic regression 59 rs# [001] 59 Response Evaluation Criteria 59 chest radiographs 59 TURBT 59 tissue oxygenation 59 #p#.# [002] 59 SMAD4 59 p# mutation 59 lymph node 59 perioperative complications 59 serum homocysteine 59 DRB1 * 59 Asymptomatic 59 Supplemental Figure 59 mammographic density 59 splenocytes 59 fig. S1 59 varicoceles 59 VATS lobectomy 59 lymphatic vessel 59 intraventricular 59 IDH1 mutation 59 leukocyte counts 59 osteoblast 59 HPV# 59 peri implant 59 prognostic factors 59 maternal serum 59 serum albumin 59 ureteral 59 IgG antibody 59 FluCAM arm 59 proton MR spectroscopy 59 chromosomal aberrations 59 μmol L 59 IGFBP 59 CD3 + 59 E. faecalis 59 relapsed MM 59 urothelium 59 Multivariate analyzes 59 STRIDE PD 59 superior mesenteric artery 59 serum biomarker 59 glutamate glutamine 59 #p# [001] 59 antibody titer 59 aggregated Abeta 59 neutrophil count 59 TGF alpha 59 intra tumoral 59 DNMT1 59 benign lesions 59 conjunctival